Search
galsulfase (Naglazyme)
Trademark: Naglazyme, FDA approved 2005
Indications:
- enzyme for patients with mucopolysaccharidosis VI
Mechanism of action:
- enzyme replacement Manufacturers: BioMarin
General
immune globulin (Gamastan, Gamimune N, Gammagard, Gammar, Sandoglobulin, Venoglobulin-I, Venoglobulin-S, ISG, Vivaglobulin, Gamunex, Privigen, Gammaplex, Flebogamma, Gammaked, Bivigam, Carimune, Hizentra)
References
Prescriber's Letter 13(2): 2006
Detail-Document#: 220215
(subscription needed) http://www.prescribersletter.com